US Patent 12,409,347 — assignment history and current owner

US 12,409,347 · Application 18/762,296

Betacoronavirus Mrna Vaccines

Who owns US Patent 12,409,347?

US12409347 ("Betacoronavirus Mrna Vaccines") — current assignee: MODERNATX, INC.. Status: Active, estimated expiration October 21, 2036. 2 recorded USPTO assignments.

Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 12,409,347 is MODERNATX, INC.. Based on the most recent ownership transfer record (recorded 2024-12-09).

Patent title
Betacoronavirus Mrna Vaccines
Application number
18/762,296
Apparent operating assignee
MODERNATX, INC.
Patent status
Active, estimated expiration October 21, 2036
Recorded assignments
2

Note: a security interest appears active (ARES CAPITAL CORPORATION, AS AGENT) with no recorded release. Security interests reflect financing arrangements, not operating ownership.

Recorded assignment history

ExecutedRecordedConveyanceAssignor(s)Assignee(s)Reel/frame
Apr 28, 2017Dec 9, 2024Ownership TransferHIMANSU, SUNNY; CIARAMELLA, GIUSEPPEMODERNATX, INC.69530/106
Nov 19, 2025Nov 19, 2025Security InterestMODERNATX, INC.ARES CAPITAL CORPORATION, AS AGENT73634/354

Scrolls sideways on narrow screens

Chain of title

In 2024, HIMANSU, SUNNY; CIARAMELLA, GIUSEPPE assigned the patent to MODERNATX, INC.. In 2025, ARES CAPITAL CORPORATION, AS AGENT recorded a security interest; this reflects a financing arrangement, not a change in operating ownership.

Apparent recorded rights summary — disclaimer

This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.

Ownership settled? Give your AI the file.

Application 18/762,296 · US 12,409,347

The recorded chain of title is one part of the record. PatentReply compiles the rest of US 12,409,347, from the claims as filed to the last action, for Claude, ChatGPT, Grok, or another supported AI client.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.